Schneider Children's Medical Center of Israel

Petach Tikvah 4920235

2 studies enrolling now · 8 studies all time

What they study most

CPSS (Congenital Portosystemic Shunt), Chronic Pseudomonas Aeruginosa Infection, Congenital Portosystemic Shunt, Cystic Fibrosis, Duchenne Muscular Dystrophy, Hyperkalemia

Studies at this site

• Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age — Recruiting now
• Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular Dystrophy — Running, not enrolling
• A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy — Running, not enrolling
• Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection — Completed
• International Registry of Congenital Portosystemic Shunt (IRCPSS) — Enrolling by invitation
• A Phase 3 Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Heterozygous for F508del and a Minimal Function Mutation (F/MF) — Completed
• A Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Residual Function (F/RF) Mutation, or Have At Least 1 Other Triple Combination Responsive (TCR) CFTR Mutation and No F508del Mutation — Completed
• Longitudinal Study of the Natural History of Duchenne Muscular Dystrophy (DMD) — Status unconfirmed